secwatch.observer — SEC 8-K summary
======================================

Issuer:     Owlet, Inc. (OWLT)
CIK:        0001816708
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001628280-24-009645
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owlet Q4 revenue $21M, net loss down 65% YoY; FY23 gross margin up 810 bps
--------------------------------------------------------------------------

- Q4 revenue ~$21.0M; gross margin 47.1%; net loss ~$6.9M vs $19.5M YoY.
- FY 2023 revenue ~$54.0M (down from $69.2M in 2022); gross margin 41.8% (up from 33.7%).
- Adjusted EBITDA loss Q4 ~$0.7M (down 95% YoY); FY ~$16.3M (down 76% YoY).
- CEO cites two FDA authorizations, commercializing medical devices, and expanding healthcare distribution.
- Net loss per share FY 2023 $4.53 compared to $9.98 in 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816708/000162828024009645/0001628280-24-009645-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816708/000162828024009645/owlt-20240307.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-009645

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer